Results 211 to 220 of about 168,165 (319)
Donor History of Drug Use and Graft Survival in Pediatric Heart Transplant Recipients.
Esteso P+6 more
europepmc +1 more source
Survival of composite chondrocutaneous grafts by vessel implantation: A study in the rabbit ear model [PDF]
Richard L. Arden+4 more
openalex +1 more source
Hepatoblastoma, an aggressive childhood liver tumor, origins from malignant hepatoblast‐like cells. Single‐cell analysis reveals IGF2‐driven pathways promoting malignancy. Targeting these pathways offers promising treatments, with serum IGF2 as a potential diagnostic biomarker.
Miao Ding+12 more
wiley +1 more source
MICA and NKG2D gene polymorphisms influence graft survival, and response to therapy in kidney transplantation. [PDF]
Littera R+25 more
europepmc +1 more source
LACK156‐173 is internalized into RA‐FLSs via CAPN2‐mediated endocytosis and inhibits the aggressive phenotype of RA‐FLSs by restoring dysregulated fatty acid synthesis metabolism mediated by overexpressed FASN. The findings suggest that targeting the restoration of fatty acid metabolism could potentially alleviate synovial invasion and joint damage in ...
Jianling Su+17 more
wiley +1 more source
The effect of low donor-to-recipient body weight ratio on graft survival after dual kidney transplantation from pediatric deceased donors. [PDF]
Huang M+16 more
europepmc +1 more source
Recent Advancements in Lung Cancer Metastasis Prevention Based on Nanostrategies
Metastasis is the leading cause of death in patients with lung cancer. Nanomedicine can be used to prepare efficient drug delivery systems owing to their advantages and plays an important role in the synergistic antimetastasis of lung cancer. This comprehensive review summarizes the emerging nanostrategies against lung cancer metastasis based on the ...
Fan Xu+7 more
wiley +1 more source